UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
- 1. 成人における双極性障害：第2世代抗精神病薬による大うつ病の治療 bipolar disorder in adults treating major depression with second generation antipsychotics
- 2. 成人における双極性障害：抗うつ剤による大うつ病エピソードの治療 bipolar disorder in adults treating major depression with antidepressants
- 3. 成人における急速交代性の双極性障害：大うつ病の治療 rapid cycling bipolar disorder in adults treatment of major depression
- 4. 小児の双極性障害（大うつ病エピソード）：治療法の選択 pediatric bipolar major depression choosing treatment
- 5. 妊娠女性における双極性障害：大うつ病の治療 bipolar disorder in pregnant women treatment of major depression
English Journal
- Important clinical features of atypical antipsychotics in acute bipolar depression that inform routine clinical care: a review of pivotal studies with number needed to treat.
- Gao K1, Yuan C, Wu R, Chen J, Wang Z, Fang Y, Calabrese JR.
- Neuroscience bulletin.Neurosci Bull.2015 May 30. [Epub ahead of print]
- English-language literature cited in MEDLINE from January, 1980 to October 30, 2014 was searched by using terms of antipsychotic, generic and brand names of atypical antipsychotics, "bipolar depression/bipolar disorder", "placebo", and "trial". The parameters of response (≥50% improvement on MADRS
- PMID 26024955
- The pharmacodynamic properties of lurasidone and their role in its antidepressant efficacy in bipolar disorder.
- Fountoulakis KN1, Gazouli M2, Kelsoe J3, Akiskal H4.
- European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology.Eur Neuropsychopharmacol.2015 Mar;25(3):335-42. doi: 10.1016/j.euroneuro.2014.11.010. Epub 2014 Nov 29.
- The treatment of bipolar depression is one of the most challenging issues in contemporary psychiatry. Currently only quetiapine, the olanzapine-fluoxetine combination and recently lurasidone are officially FDA-approved against this condition. The neurobiology of bipolar depression and the possible t
- PMID 25596883
- [Acute pharmacotherapy for anxiety symptoms in patients with depression].
- Quante A.
- Fortschritte der Neurologie-Psychiatrie.Fortschr Neurol Psychiatr.2015 Mar;83(3):142-8. doi: 10.1055/s-0034-1399243. Epub 2015 Mar 20.
- Patients with depression often also present symptoms of anxiety. First-line pharmacotherapy of comorbid symptoms of depression and anxiety is often a combination therapy of an antidepressant agent, which is combined with benzodiazepines. However, benzodiazepines pose the drawbacks of being associate
- PMID 25794319
Related Links
- Symbyax (fluoxetine and olanzapine) is used to treat depression caused by bipolar disorder. Includes Symbyax side effects, interactions and indications. ... Symbyax side effects Get emergency medical help if you have any of these ...
- 4 • Do not take an MAOI within 5 weeks of stopping SYMBYAX unless directed to do so by your physician. • Do not start SYMBYAX if you stopped taking an MAOI in the last 2 weeks unless directed to do so by your physician.
Related Pictures
